PSMA PET Combined With MRI for the Detection of PCa

Clinical trial NCT07052214 · RECRUITING

Trial details

NCT number: NCT07052214
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

PCA Prostate Cancer Prostatic Neoplasm PSMA PET Diagnostic Imaging Elevated PSA Positron Emission Tomography Prostate Biopsy Carcinoma of the Prostate

Start date: 2025-08-18
Primary completion: 2027-01-01
Enrollment: 338

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.